|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, 467-476, March 2009 Mucosal IgA increase in rats by continuous CLA feeding during suckling and early infancy
* Department of Physiology, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain This study was funded in part by the Generalitat de Catalunya (SGCR-2005-00833). C. C. and A. F. acknowledge partial funding for this research from CIBER Epidemiología y Salud Pública (CIBERESP), Spain. C. R. S. has a grant from Agencia Española de Cooperación Internacional. The oil used in the study was a gift from Loders Croklaan, Lipid Nutrition, Wormerveer, The Netherlands. Published, JLR Papers in Press, September 29, 2008.
1 To whom correspondence should be addressed. e-mail: franciscoperez{at}ub.edu
The aim of this work was to establish the effect of the cis9,trans11 conjugated linoleic acid (CLA) isomer on mucosal immunity during early life in rats, a period when mucosal immunoglobulin production is poorly developed, as is also the case in humans. CLA supplementation was performed during three life periods: gestation, suckling, and early infancy. The immune status of supplemented animals was evaluated at two time points: at the end of the suckling period (21-day-old rats) and 1 week after weaning (28-day-old rats). Secretory IgA was quantified in intestinal washes from 28-day-old rats by ELISA technique. IgA, TGFβ, and PPAR
Supplementary key words gestation mucosal immunity conjugated linoleic acid
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||